BRIEF — Insmed Incorporated — Launches Four Pivotal Phase 3 Studies For TPIP In Pulmonary Diseases
Oct 15 (Reuters) — Insmed Incorporated: Insmed Incorporated - Launches Four Pivotal Phase 3 Studies For Tpip In Pulmonary Diseases Insmed Incorporated - Three Phase 3 Studies Initiated; Fourth To Begin In First Half Of 2027 Source text:... Further company coverage: INSM.O (Reuters.Briefs@thomsonreuters.com;)